FibroGen financials at a glance
| Year | Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$137.60M | $180.83M | $183.19M | $131.00M | $212.96M | $256.58M | $176.32M | $235.31M | $140.73M | $147.75M | $0.00M |
| GM % | Gross Margin % |
|
-9.59% | -18.39% | -2.19% | -50.02% | -10.74% | 17.99% | -48.48% | -65.40% | -113.13% | -109.36% | 0.00% |
| OM | Operating Margin |
|
-36.41% | -42.93% | -27.32% | -89.53% | -40.71% | -34.81% | -108.83% | -122.62% | -213.90% | -198.88% | 0.00% |
| EPS | Earnings Per Share |
|
$-1.01 | $-1.42 | $-0.98 | $-1.73 | $-1.03 | $-0.89 | $-2.11 | $-3.14 | $-3.14 | $-2.79 | $0.00 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
-0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | 0 |
| Sha. | Shares |
|
57.86m | 61.34m | 63.16m | 82.01m | 84.98m | 87.25m | 91.01m | 92.71m | 93.29m | 0m | 98.77m |
| OCF | Operating Cash Flow |
|
$22.41M | $-18.57M | $7.11M | $-66.51M | $-76.14M | $-78.71M | $81.60M | $-82.23M | $-145.93M | $-315.02M | $0.00M |
| FCF | Free Cash Flow |
|
$14.29M | $-20.55M | $-124.65M | $-75.01M | $-84.16M | $-84.47M | $77.61M | $-87.42M | $-149.67M | $-221.00M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$0.76 | $-0.34 | $0.09 | $-1.03 | $-1.00 | $-0.97 | $0.86 | $-1.22 | $-1.97 | $-3.26 | $0.00 |